Parenteral Nutrition: Adjunctive or Primary Role in Gastrointestinal Therapeutics?

Abstract

Get full access to this article

View all access options for this article.

References

1. Steinberg W , Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198–210.

2. McKay CJ , Imrie CW , Baxter JN . Sandostatin and sandostatin analogues—are they indicated in the management of acute pancreatitis? Gut 1993;34:1622–6.

3. Buchler M , Friess H , Klempa I, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992;163:125–31.

4. Banks PA . Practice guidelines in acute pancreatitis. Am J Gastroenterol 1997;92:377–86.

5. Klein S , Kinney J , Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. JPEN 1997;21:133–56.

6. Van Der Hulst RRWJ , Von Meyenfeldt MF , Tiebosch A, et al. Glutamine and intestinal immune cells in humans. JPEN 1997;21:310–5.

7. Beluzzi A , Brignola C , Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334:1557–60.

8. Loeschke K , Uebershaer B , Pietsch A, et al. N-3 Fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 1996;41:2087–94.

9. Scheppach W , Sommer H , Kirchmer T, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992;103:51–6.

10.

10. Mosdell KW , Visconti JA . Emerging indications for octreotide therapy, part 2. Am J Hosp Pharm 1994;51:1317–30.

11.

11. Harris AG . Octreotide in the treatment of disorders of the gastrointestinal tract. Drug Invest 1992;4:1–54.

12.

12. Prinz RA , Pickleman J , Hoffman JP . Treatment of pancreatic cutaneous fistulas with a somatostatin analog. Am J Surg 1988;155:36–42.

13.

13. Sancho JJ , DiCostanzo J , Nubiola P, et al. Randomized double blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995;82:638–41.

14.

14. Ritchie DJ , Holstad SG , Westrich TJ, et al. Activity of octreotide acetate in a total nutrient admixture. Am J Hosp Pharm 1991;48:2172–5.

15.

15. O'Keefe SJ , Peterson ME , Fleming CR . Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. JPEN 1994;18:26–34.

16.

16. Howard L , Ament M , Fleming CR, et al. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995;109:355–65.

17.

17. Vand Der Hulst RRW , Van Kreel BK, et al. Glutamine and the preservation of gut integrity. Lancet 1993;341:1363–5.

18.

18. Wilmore DW , Byrne TA , Persinger RL, et al. A new treatment for patients with short bowel syndrome: growth hormone, glutamine and a modified diet. Ann Surg 1995;222:243–55.

19.

19. Wilmore DW , Lacey JM , Soultamakis RP, et al. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 1997;226:288–93.